Skip to main content

Table 1 Baseline characteristics of patients according to FPG

From: Effects of fasting hyperglycemia in men on pregnancy outcomes of singleton pregnant women with cryo-thawed embryo transfer

Characteristic

FH (n = 29)

Con (n = 341)

P-value

Male age (y)

37.2 ± 5.8

33.0 (31.0–36.5)

0.003*

Male BMI (Kg/m2)

29.0 ± 3.9

24.9 (23.2–27.4)

 < 0.001*

 < 25 (%)

4 (13.8)

172 (50.4)

 

 ≥ 25 (%)

25 (86.2)

169 (49.6)

 

Female age at CET (y)

32.8 ± 4.3

32.0 (30–34)

0.004*

Female BMI (Kg/m2)

21.5 ± 1.5

21.5 (20.0–23.1)

0.961

No. of prior COH cycles

1.0 (1.0–1.0)

1.0 (1.0–1.0)

0.130

No. of prior ET cycles

0.0 (0.0–1.0)

0.0 (0.0–1.0)

0.643

Causes of infertility (%)

  

0.073

 Female

20 (69.0)

215 (63.0)

 

 Male

1 (3.4)

18 (5.3)

 

 Female and male

2 (6.9)

30 (8.8)

 

 Others

6 (20.7)

78 (22.9)

 

Category of sterility (%)

 Primary

11 (37.9)

213 (62.5)

0.009*

 Secondary

18 (62.1)

128 (37.5)

 

Duration of infertility (y)

  

0.239

 < 2 (%)

13 (44.8)

101 (29.6)

 

 2–5 (%)

13 (44.8)

186 (54.5)

 

 > 5 (%)

3 (10.3)

54 (15.8)

 

Years of treatment (y)

0.7 (0.5–1.2)

0.5 (0.4–0.9)

0.017*

Method of fertilization (%)

  

0.221

 IVF

25 (86.2)

264 (77.4)

 

 ICSI

4 (13.8)

62 (18.2)

 

 IVF + ICSI

0 (0)

15 (4.4)

 

No. of total embryos transferred

1 (1–2)

2 (1–2)

0.039*

Development stage of CET embryos (%)

  

0.496

 Day 3

14 (48.3)

187 (54.8)

 

 Day 5–6

15 (51.7)

154 (45.2)

 

Endometrium thickness (mm)

9.0 (8.5–10.5)

9.9 (8.1–11.0)

0.700

Endometrium morphology (%)

  

0.908

 A

17 (58.6)

187(54.8)

 

 A-

8 (27.6)

106 (31.1)

 

 Others

4 (13.8)

48 (14.1)

 

Endometrium preparation (%)

  

0.434

 Natural cycle

11 (37.9)

128 (37.5)

 

 HRT cycle

17 (58.6)

210 (61.6)

 

 Stimulation cycle

1 (3.4)

3 (0.9)

 
  1. Data are shown as mean ± SD, median (IQR) or n (%). The characteristics are the basic patient information routinely provided in ART. *P < 0.05 compared with the control group. FPG fasting plasma glucose, FH fasting hyperglycemia, BMI body mass index, COH controlled ovarian hyperstimulation, ET embryo transfer, IVF in vitro fertilization, ICSI intracytoplasmic sperm injection, CET cryo-thawed embryo transfer, HRT hormone replacement therapy